A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer

PURPOSE: The noninterventional, prospective NIMES‐ROC phase IV study (NCT02825420) evaluated trabectedin plus pegylated liposomal doxorubicin (PLD) in real‐life clinical practice. PATIENTS AND METHODS: Eligible participants included adults with platinum‐sensitive recurrent ovarian cancer (PS‐ROC) wh...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Pignata, Sandro, Scambia, Giovanni, Villanucci, Alessandro, Naglieri, Emanuele, Ibarbia, Mikel Arruti, Brusa, Federica, Bourgeois, Hugues, Sorio, Roberto, Casado, Antonio, Reichert, Dietmar, Dopchie, Catherine, De Rivas, Beatriz, de Sande, Luis Miguel
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Assuntos:
Gynecologic Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018301/
https://ncbi.nlm.nih.gov/pubmed/33289956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13630
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares